Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old
Clinical trial NCT01236040 · COMPLETED
Trial details
- NCT number
- NCT01236040
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-29
- Primary completion
- 2011-09-06
- Enrollment
- 521
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.